A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
UroGen Pharma Ltd.
Corewell Health West
UroGen Pharma Ltd.
Viralytics
Halozyme Therapeutics
UroGen Pharma Ltd.
Duke University
University of Rome Tor Vergata
University of Rome Tor Vergata
Eli Lilly and Company